Net Cash Provided by (Used in) Operating Activities in USD of ABVC BIOPHARMA, INC. from 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
ABVC BIOPHARMA, INC. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and change rate from 2010 to Q1 2025.
  • ABVC BIOPHARMA, INC. Net Cash Provided by (Used in) Operating Activities for the quarter ending 31 Mar 2025 was -$540K, a 43.5% increase year-over-year.
  • ABVC BIOPHARMA, INC. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$1.81M, a 56.8% increase from 2023.
  • ABVC BIOPHARMA, INC. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$4.19M, a 43.4% increase from 2022.
  • ABVC BIOPHARMA, INC. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$7.4M, a 2.62% increase from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Change (%)

ABVC BIOPHARMA, INC. Quarterly Net Cash Provided by (Used in) Operating Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 -$540K +$416K +43.5% 01 Jan 2025 31 Mar 2025 10-Q 30 Apr 2025
Q1 2024 -$956K +$542K +36.2% 01 Jan 2024 31 Mar 2024 10-Q 30 Apr 2025
Q1 2023 -$1.5M +$1.5M +50% 01 Jan 2023 31 Mar 2023 10-Q 17 May 2024
Q1 2022 -$2.99M -$1.58M -112% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q1 2021 -$1.41M -$782K -124% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022
Q1 2020 -$631K -$31.4K -5.24% 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021
Q1 2019 -$600K -$74K -14.1% 01 Jan 2019 31 Mar 2019 10-Q 29 Jun 2020
Q1 2018 -$526K +$337K +39.1% 01 Jan 2018 31 Mar 2018 10-Q 28 May 2019
Q4 2017 -$112K 01 Oct 2017 31 Dec 2017 10-KT 13 Apr 2018
Q1 2017 -$862K 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018
Q4 2014 $0 +$10.00 01 Oct 2014 31 Dec 2014 10-Q 17 Apr 2015
Q3 2014 -$6.8K 19 Sep 2014 30 Sep 2014 10-K 27 Nov 2015
Q4 2013 -$10* +$36.3K 01 Oct 2013 31 Dec 2013 10-Q 17 Apr 2015
Q4 2012 -$36.4K +$330K +90.1% 01 Oct 2012 31 Dec 2012 10-Q 17 Apr 2015
Q4 2011 -$367K -$213K -139% 01 Oct 2011 31 Dec 2011 10-Q 16 Apr 2015
Q4 2010 -$153K 01 Oct 2010 31 Dec 2010 10-Q 21 Feb 2012

ABVC BIOPHARMA, INC. Annual Net Cash Provided by (Used in) Operating Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$1.81M +$2.38M +56.8% 01 Jan 2024 31 Dec 2024 10-K 15 Apr 2025
2023 -$4.19M +$3.21M +43.4% 01 Jan 2023 31 Dec 2023 10-K 15 Apr 2025
2022 -$7.4M +$199K +2.62% 01 Jan 2022 31 Dec 2022 10-K 13 Mar 2024
2021 -$7.6M -$3.03M -66.5% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023
2020 -$4.56M -$1.43M -45.6% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022
2019 -$3.13M -$2.23M -248% 01 Jan 2019 31 Dec 2019 10-K 16 Mar 2021
2018 -$901K +$585K +39.4% 01 Jan 2018 31 Dec 2018 10-K 15 May 2020
2017 -$1.49M +$1.99M +57.3% 01 Jan 2017 31 Dec 2017 10-K 15 Apr 2019
2016 -$3.47M -$3.48M -103514% 01 Oct 2015 30 Sep 2016 10-KT 13 Apr 2018
2015 $3.36K +$2.19K 01 Oct 2014 30 Sep 2015 10-K 27 Nov 2015
2014 $1.17K* +$38.9K 01 Oct 2013 18 Sep 2014 10-K 27 Nov 2015
2013 -$37.8K +$877K +95.9% 01 Oct 2012 30 Sep 2013 10-K 16 Apr 2015
2012 -$915K +$678K +42.6% 01 Oct 2011 30 Sep 2012 10-K 16 Apr 2015
2011 -$1.59M -$546K -52.1% 01 Oct 2010 30 Sep 2011 10-K 15 Apr 2015
2010 -$1.05M 01 Oct 2009 30 Sep 2010 10-K/A 28 Dec 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.